Skip to main content
Alexander Pearson, MD, Oncology, Chicago, IL, University of Chicago Medical Center

AlexanderT.PearsonMDPhD

Oncology Chicago, IL

Head & Neck Cancer

Assistant Professor of Medicine; Director, University of Chicago Head/Neck Cancer Program Director, Data Sciences in Hematoloy/Oncology

Overview of Dr. Pearson

Dr. Alexander Pearson is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 7 years. He specializes in head & neck cancer and is experienced in neoplasms of the salivary glands and head and neck oncology.

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2017
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 2010 - 2013
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2010

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2017 - 2026
  • MI State Medical License
    MI State Medical License 2010 - 2020
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Leif B. Sorenson Award The University of Chicago Department of Medicine, 2022
  • NextGen Innovator HemOnc Today, 2019
  • 40 under 40 Chicago Scientists HaloCures, 2019

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ChatGPT Writes Convincing Fake Scientific Abstracts That Fool Reviewers in Study
    ChatGPT Writes Convincing Fake Scientific Abstracts That Fool Reviewers in StudyJanuary 10th, 2023
  • First He Survived Cancer – Now He Studies It
    First He Survived Cancer – Now He Studies ItNovember 14th, 2022
  • ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in Cancer
    ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
  • Join now to see all

Grant Support

  • A reasoned approach to combination therapy development in head and neck cancerNIH/NIDCRPresent

Hospital Affiliations